Massachusetts Biomedical Initiatives (MBI)’s Post

A huge part of my job & Massachusetts Biomedical Initiatives (MBI)'s mission is centered around growing the region's #lifesciences industry through #advocacy and #workforcedevelopment. After working with countless partners, we have developed a Regional Biomanufacturing Strategy that outlines the steps we need to take to continue that growth. The success of the life sciences in Central MA directly impacts the success of our region. While it is less than an hour away, #Boston alone cannot contain the industry's exponential growth. Central MA has the space, workforce #talent, and other resources vital to growing companies of all sizes (plus it is WAY more cost effective to life and operate a business here). Please take a second to read through our strategy and see what my team at MBI envisions for the future of #CentralMA... we are on our way to do some really great things for our region! #BiomanufacturingCentralMA #CentralMABioCluster

The Office of Massachusetts Governor Maura Healey's #MassLeadsAct would mean more #jobs, reduced #drug costs, and strengthened #infrastructure for Central Massachusetts. MBI is working tirelessly to ensure that Central Massachusetts is designated a #global #bioindustrial and #biomanufacturing hub. #Startupfounders like Lina M. González ♻️, founder of SpadXTech, "credits MBI with affording her a financially feasible way to launch her own startup ...The availability of physical space to turn #research into #manufacturing facilities distinguishes Central MA from other tech-heavy #hubs of the state, such as #Boston & #Cambridge." Our dedication to building up the #CentralMABioCluster is helping the #lifesciences grow within our region and the Mass Leads Act Bill will help the #cluster continue to grow & positively impact our greater #community. #Woomentum #STEM #legislation #Governor #TeamMassachusetts #workforcedevelopment #clusterdevelopment #economicdevelopment

A fascinating and experience-driven article highlighting the significant impact of policy on becoming a leading state in biotech. It underscores the importance of carrying good policy forward. Truly insightful! Keep it up Livio Valenti!

💸 iFAB Tech Hub has been awarded approximately $51 million to enhance biomanufacturing and precision fermentation capabilities in Central Illinois. Learn more → https://bit.ly/3LhlbKV Awarded by the U.S. Department of Commerce Economic Development Administration (EDA) in the form of an implementation grant, the funding will help position Central Illinois as a global leader in biomanufacturing and precision fermentation, supporting national security, economic growth, and job generation. The funding is part of the Biden-Harris Administration’s Tech Hubs Program, a national initiative aimed at investing in and growing regional bioeconomies and workforce development in critical technologies across the country, and follows $680 million in funding announced earlier this year. “Central Illinois is uniquely positioned to lead the way in biomanufacturing, leveraging an ecosystem of industry leaders, innovative startups, world-class R&D, scalable infrastructure, abundant feedstock production, and robust transportation networks,” said iFAB leader Nicole Bateman, president of the Economic Development Corporation of Decatur & Macon County. It's truly energizing to see continued substantial public support for #alternativeproteins to foster vibrant regional bioeconomies in the Midwest. 👏

💸 iFAB Tech Hub has been awarded approximately $51 million to enhance biomanufacturing and precision fermentation capabilities in Central Illinois. Learn more → https://bit.ly/3LhlbKV Awarded by the U.S. Department of Commerce Economic Development Administration (EDA) in the form of an implementation grant, the funding will help position Central Illinois as a global leader in biomanufacturing and precision fermentation, supporting national security, economic growth, and job generation. The funding is part of the Biden-Harris Administration’s Tech Hubs Program, a national initiative aimed at investing in and growing regional bioeconomies and workforce development in critical technologies across the country, and follows $680 million in funding announced earlier this year. “Central Illinois is uniquely positioned to lead the way in biomanufacturing, leveraging an ecosystem of industry leaders, innovative startups, world-class R&D, scalable infrastructure, abundant feedstock production, and robust transportation networks,” said iFAB leader Nicole Bateman, president of the Economic Development Corporation of Decatur & Macon County. It's truly energizing to see continued substantial public support for #alternativeproteins to foster vibrant regional bioeconomies in the Midwest. 👏

🔬Life Sciences: What’s next for this high growth market in the UK? We recently attended a Life Sciences conference in London, providing the latest insight into this sector. Despite its reputation as a high growth area, UK life sciences contributes just 2% to this market globally. And with only four of the top 100 Biotech / Life Sciences businesses parented in the UK, you could be forgiven for thinking this is a negative thing. In fact, it represents a HUGE opportunity for the UK – one which we’ve been alive to for many years now. So, what is next for this high growth market and what do investors need to do to take advantage of it? Agency partner, Guy Parkes, discusses in this article which explores: ✅How to attract more life sciences businesses ✅The need for more VC investment  ✅What lab and biotech occupiers want from their property ✅Future growth & opporrtunities in this sector https://lnkd.in/eCRv3Adz #lifesciences #labspace #biotech #researchanddevelopment #research #development #commercialproperty #commercialrealestate

The Life Science sector in the UK continues to show massive growth potential. There is 1.7m sq ft of demand in the life science sector at the moment, in the UK. However, there is only around 400,000 sq ft of appropriate lab and biotech space readily available. Learn how developers are plugging this gap and counterbalancing the carbon impact of construction.

Thrilled to share my recent op-ed in Bio Futures magazine... In this piece, I delve into the real estate challenges and solutions for Indiana’s life sciences sector. Here are three key takeaways: - Real Estate Investment Landscape: Indiana faces a scarcity of third-party investors compared to major life sciences hubs. While these hubs boast 55% ownership by private developers and REITs, our local market struggles to attract similar capital. My op-ed explores strategies to bridge this gap and foster investment growth. - Startup Support: Early-stage biotech startups are the lifeblood of innovation. However, they often lack access to essential resources. Co-working labs can play a pivotal role in nurturing these startups, providing collaborative spaces where breakthroughs happen. Let’s champion co-working lab initiatives to empower our local entrepreneurs. - Infrastructure Funding: Leveraging Tax Increment Financing (TIF) districts presents an exciting opportunity. By directing TIF funds toward life sciences infrastructure, we can enhance research facilities, attract talent, and elevate Indiana’s prominence in the industry. Read my full op-ed here: https://lnkd.in/gcxgPRQF Let’s continue driving innovation and growth in Indiana’s life sciences sector. #LifeSciences #Indiana #Innovation Jon R. Owens, SIOR Kristin Jones Indiana Health Industry Forum

The Boston Biotech Hub and North Carolina Research Triangle Park, economics and infrastructure compared. Lower cost of living, ease of building infrastructure, and state incentive investment in biotech, all contribute to the dominance of RTP as a manufacturing hub for biopharma. It is good to have alternative locations for biotech success. Boston Globe - " Maintaining Massachusetts’ competitive edge is top of mind these days for political and business leaders alike. And, to be clear, few places on the planet compare to Greater Boston’s drugmaking expertise. But the life science industry isn’t just about researchers with PhDs. New drugs have to be physically produced somewhere, too. And while biotech has become the crown jewel of Greater Boston’s economy, other parts of the country are eager to pluck a few of those gems for themselves. " https://lnkd.in/eh58gqvZ

I was scrolling through Crain's today when i saw Samir Mayekar article shedding light on Chicago's innovation surge! 🙌 Key points: 1. Post-pandemic, Chicago is thriving in science-based collaborations, 2. notable achievements like the $250 million Chan Zuckerberg Biohub and the Chicagoland Climate Investment Alliance. 3. President Biden's $1 billion hydrogen hub, these incredible achievements of Chicago showcase the city's commitment to solving global challenges. Universities, like Northwestern University and The University of Chicago Booth School of Business, are securing millions for groundbreaking research, while new lab facilities from Hyde Park to Evanston signal infrastructure growth. Mayekar emphasizes continued collaboration as we approach transformative federal investments of over $200 billion in R&D. Let's propel Chicago to be the global hub for scientific breakthroughs! 🌟 I am thrilled to have a part in the innovation sector here in Chicago at Illinois Science and Technology Coalition Kate Calabra Colleen D Egan Anne Marie Rzepecki #ChicagoInnovation #ScienceRising #CollaborateForChange #chicagoland #innovation #ScientificBreakthroughs #CollaborationWins